Advertisement
American Journal of Kidney Diseases

Heart Failure–Type Symptom Score Trajectories in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

  • Carl P. Walther
    Correspondence
    Corresponding author: Carl P. Walther, MD, MS, One Baylor Plaza, Houston, TX 77030,
    Affiliations
    Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, TX
    Search for articles by this author
  • Julia S. Benoit
    Affiliations
    Texas Institute for Measurement, Evaluation, and Statistics, University of Houston, Houston, TX
    Search for articles by this author
  • Nisha Bansal
    Affiliations
    Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, WA
    Search for articles by this author
  • Vijay Nambi
    Affiliations
    Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX

    Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX
    Search for articles by this author
  • Sankar D. Navaneethan
    Affiliations
    Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, TX

    Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX

    Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, TX
    Search for articles by this author
  • on behalf of theCRIC Study Investigators
    Author Footnotes
    CRIC Study Investigators: Harold I. Feldman, MD, MSCE, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O Shah, PhD, MS, Mark L. Unruh, MD, MS.
  • Author Footnotes
    CRIC Study Investigators: Harold I. Feldman, MD, MSCE, Lawrence J. Appel, MD, MPH, Jing Chen, MD, MMSc, MSc, Debbie L. Cohen, MD, Alan S. Go, MD, James P. Lash, MD, Robert G. Nelson, MD, PhD, MS, Mahboob Rahman, MD, Panduranga S. Rao, MD, Vallabh O Shah, PhD, MS, Mark L. Unruh, MD, MS.
Published:November 17, 2022DOI:https://doi.org/10.1053/j.ajkd.2022.09.016

      Abstract

      Rationale & Objective

      Quality of life in chronic kidney disease (CKD) is impaired by a large burden of symptoms including some that overlap with the symptoms of heart failure (HF). We studied a group of individual with CKD to understand the patterns and trajectories of HF-type symptoms in this setting.

      Study Design

      Prospective cohort study.

      Setting & Participants

      3,044 participants in the Chronic Renal Insufficiency Cohort (CRIC) without prior diagnosis of HF.

      Predictors

      Sociodemographics, medical history, medications, vital signs, laboratory values, echocardiographic and EKG parameters.

      Outcomes

      Trajectory over 5.5 years of a HF-type symptom score (modified Kansas City Cardiomyopathy Questionnaire [KCCQ] Overall Summary Score with a range of 0-100 where <75 reflects clinically significant symptoms).

      Analytical Approach

      Latent class mixed models were used to model trajectories. Multinomial logistic regression was used to model relationships of predictors with trajectory group membership.

      Results

      Five trajectories of KCCQ score were identified in the cohort of 3,044 adults, 45% of whom were female, and whose median age was 61 years. Group 1 (41.7%) had a stable high score (minimal symptoms, average score of 96); Groups 2 (35.6%) and 3 (15.6%) had stable but lower scores (mild symptoms, average 81, and clinically significant symptoms, average 52, respectively). Group 4 (4.9%) had a substantial worsening in symptoms over time (mean 31-point decline) and Group 5 (2.2%) had a substantial improvement (mean 33-point increase) in KCCQ score. A majority of Group 1 was male, non-diabetic, non-obese, and had higher baseline kidney function. A majority of Groups 2 and 3 had diabetes and obesity. A majority of Group 4 was male and had substantial proteinuria. Group 5 had the highest proportion of baseline cardiovascular disease (CVD).

      Limitations

      No validation cohort available, CKD management changes in recent years may alter trajectories, and latent class models depend on the missing at random assumption.

      Conclusions

      Distinct HF-type symptom burden trajectories were identified in the setting of CKD, corresponding to different baseline characteristics. These results highlight the diversity of HF-type symptom experiences in individuals with CKD.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yapa H.E.
        • Purtell L.
        • Chambers S.
        • Bonner A.
        The Relationship Between Chronic Kidney Disease, Symptoms and Health-Related Quality of Life: A Systematic Review.
        J Ren Care. Jun. 2020; 46: 74-84https://doi.org/10.1111/jorc.12303
        • Brown S.A.
        • Tyrer F.C.
        • Clarke A.L.
        • et al.
        Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy.
        Clinical Kidney Journal. 2017; 10: 788-796https://doi.org/10.1093/ckj/sfx057
        • Abdel-Kader K.
        • Unruh M.L.
        • Weisbord S.D.
        Symptom burden, depression, and quality of life in chronic and end-stage kidney disease.
        Clinical journal of the American Society of Nephrology : CJASN. 2009; 4: 1057-1064https://doi.org/10.2215/CJN.00430109
        • Almutary H.
        • Bonner A.
        • Douglas C.
        Symptom burden in chronic kidney disease: a review of recent literature.
        J Ren Care. Sep. 2013; 39: 140-150https://doi.org/10.1111/j.1755-6686.2013.12022.x
        • Park M.
        • Hsu C.Y.
        • Li Y.
        • et al.
        Associations between kidney function and subclinical cardiac abnormalities in CKD.
        J Am Soc Nephrol. Oct 2012; 23: 1725-1734https://doi.org/10.1681/ASN.2012020145
        • Bansal N.
        • Roy J.
        • Chen H.-Y.
        • et al.
        Evolution of Echocardiographic Measures of Cardiac Disease From CKD to ESRD and Risk of All-Cause Mortality: Findings From the CRIC Study.
        American Journal of Kidney Diseases. 2018; 72: 390-399https://doi.org/10.1053/j.ajkd.2018.02.363
        • Spertus J.A.
        • Jones P.G.
        • Sandhu A.T.
        • Arnold S.V.
        Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.
        J Am Coll Cardiol. Nov 17. 2020; 76: 2379-2390https://doi.org/10.1016/j.jacc.2020.09.542
        • Shlipak M.G.
        • Lash J.P.
        • Yang W.
        • et al.
        Symptoms characteristic of heart failure among CKD patients without diagnosed heart failure.
        Journal of cardiac failure. 2011; 17: 17-23
        • Mishra R.K.
        • Yang W.
        • Roy J.
        • et al.
        Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
        Circ Heart Fail. Jul 2015; 8: 702-708https://doi.org/10.1161/CIRCHEARTFAILURE.115.002097
        • McIlvennan C.K.
        • Morris M.A.
        • Guetterman T.C.
        • Matlock D.D.
        • Curry L.
        Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look.
        Circ Cardiovasc Qual Outcomes. Sep 2019; 12e005828https://doi.org/10.1161/CIRCOUTCOMES.119.005828
        • Weldring T.
        • Smith S.M.
        Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs).
        Health Serv Insights. 2013; 6: 61-68https://doi.org/10.4137/hsi.S11093
        • Van De Schoot R.
        • Sijbrandij M.
        • Winter S.D.
        • Depaoli S.
        • Vermunt J.K.
        The GRoLTS-checklist: guidelines for reporting on latent trajectory studies.
        Structural Equation Modeling: A Multidisciplinary Journal. 2017; 24: 451-467
        • Raynaud M.
        • Aubert O.
        • Reese P.P.
        • et al.
        Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
        Kidney Int. Jan. 2021; 99: 186-197https://doi.org/10.1016/j.kint.2020.07.025
        • Allen N.B.
        • Siddique J.
        • Wilkins J.T.
        • et al.
        Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age.
        JAMA. Feb 5. 2014; 311: 490-497https://doi.org/10.1001/jama.2013.285122
        • Lennon H.
        • Kelly S.
        • Sperrin M.
        • et al.
        Framework to construct and interpret latent class trajectory modelling.
        BMJ open. 2018; 8e020683
        • Portegies M.L.
        • Mirza S.S.
        • Verlinden V.J.
        • et al.
        Mid- to Late-Life Trajectories of Blood Pressure and the Risk of Stroke: The Rotterdam Study.
        Hypertension. Jun 2016; 67: 1126-1132https://doi.org/10.1161/HYPERTENSIONAHA.116.07098
        • Zheng Z.
        • Waikar S.S.
        • Schmidt I.M.
        • et al.
        Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study.
        J Am Soc Nephrol. Mar. 2021; 32: 639-653https://doi.org/10.1681/ASN.2020030239
        • Vistisen D.
        • Andersen G.S.
        • Hulman A.
        • Persson F.
        • Rossing P.
        • Jorgensen M.E.
        Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
        Diabetes Care. Oct 2019; 42: 1886-1894https://doi.org/10.2337/dc19-0349
        • Greene S.J.
        • Butler J.
        • Spertus J.A.
        • et al.
        Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.
        JAMA Cardiol. May 1 2021; 6: 522-531https://doi.org/10.1001/jamacardio.2021.0372
        • Feldman H.I.
        • Appel L.J.
        • Chertow G.M.
        • et al.
        The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.
        J Am Soc Nephrol. Jul. 2003; 14: S148-S153https://doi.org/10.1097/01.asn.0000070149.78399.ce
        • Lash J.P.
        • Go A.S.
        • Appel L.J.
        • et al.
        Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function.
        Clinical Journal of the American Society of Nephrology. 2009; 4: 1302https://doi.org/10.2215/CJN.00070109
        • Inker L.A.
        • Schmid C.H.
        • Tighiouart H.
        • et al.
        Estimating glomerular filtration rate from serum creatinine and cystatin C.
        N Engl J Med. Jul 5 2012; 367: 20-29https://doi.org/10.1056/NEJMoa1114248
        • Anderson A.H.
        • Yang W.
        • Hsu C.Y.
        • et al.
        Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.
        Am J Kidney Dis. Aug. 2012; 60: 250-261https://doi.org/10.1053/j.ajkd.2012.04.012
      1. Commenges D, Jacqmin-Gadda H. Dynamical biostatistical models. Chapman & Hall/CRC Biostatistics Series. CRC Press; 2016.

        • Proust-Lima C.
        • Philipps V.
        • Liquet B.
        Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package lcmm. curvilinearity; dynamic prediction; Fortran 90; growth mixture model; joint model; psychometric tests.
        R. Journal of Statistical Software. 2017-06-01 2017; 78: 56https://doi.org/10.18637/jss.v078.i02
      2. Masyn KE. Latent Class Analysis and Finite Mixture Modeling. In: Little TD, ed. The Oxford Handbook of Quantitative Methods. Oxford University Press; 2013:551-611.

        • Proust C.
        • Jacqmin‐Gadda H.
        • Taylor J.M.
        • Ganiayre J.
        • Commenges D.
        A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data.
        Biometrics. 2006; 62: 1014-1024
        • Nylund K.L.
        • Asparouhov T.
        • Muthén B.O.
        Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study.
        Structural equation modeling: A multidisciplinary Journal. 2007; 14: 535-569
        • Resnick H.E.
        • Carter E.A.
        • Aloia M.
        • Phillips B.
        Cross-sectional relationship of reported fatigue to obesity, diet, and physical activity: results from the third national health and nutrition examination survey.
        Journal of Clinical Sleep Medicine. 2006; 2: 163-169
        • Beccuti G.
        • Pannain S.
        Sleep and obesity.
        Current opinion in clinical nutrition and metabolic care. 2011; 14: 402
        • Mehta R.
        Impacts of obesity and stress on neuromuscular fatigue development and associated heart rate variability.
        International Journal of Obesity. 2015; 39: 208-213
        • Buras E.D.
        • Converso-Baran K.
        • Davis C.S.
        • et al.
        Fibro-adipogenic remodeling of the diaphragm in obesity-associated respiratory dysfunction.
        Diabetes. 2019; 68: 45-56
        • Brock J.M.
        • Billeter A.
        • Müller-Stich B.P.
        • Herth F.
        Obesity and the Lung: What We Know Today.
        Respiration. 2020; 99: 856-866
        • Davies H.O.
        • Popplewell M.
        • Singhal R.
        • Smith N.
        • Bradbury A.W.
        Obesity and lower limb venous disease–The epidemic of phlebesity.
        Phlebology. 2017; 32: 227-233
        • Savetsky I.L.
        • Torrisi J.S.
        • Cuzzone D.A.
        • et al.
        Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema.
        American Journal of Physiology-Heart and Circulatory Physiology. 2014; 307: H165-H172
        • Larsson S.C.
        • Wallin A.
        • Wolk A.
        Alcohol consumption and risk of heart failure: Meta-analysis of 13 prospective studies.
        Clin Nutr. Aug. 2018; 37: 1247-1251https://doi.org/10.1016/j.clnu.2017.05.007
        • Bundy J.D.
        • Bazzano L.A.
        • Xie D.
        • et al.
        Self-Reported Tobacco, Alcohol, and Illicit Drug Use and Progression of Chronic Kidney Disease.
        Clin J Am Soc Nephrol. Jul 6 2018; 13: 993-1001https://doi.org/10.2215/CJN.11121017
        • Bundy J.D.
        • Rahman M.
        • Matsushita K.
        • et al.
        Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
        J Am Soc Nephrol. Mar. 2022; 33: 601-611https://doi.org/10.1681/ASN.2021060747
        • Hannan M.
        • Ansari S.
        • Meza N.
        • et al.
        Risk Factors for CKD Progression: Overview of Findings from the CRIC Study.
        Clin J Am Soc Nephrol. Apr 7. 2021; 16: 648-659https://doi.org/10.2215/CJN.07830520
        • Fischer M.J.
        • Hsu J.Y.
        • Lora C.M.
        • et al.
        CKD Progression and Mortality among Hispanics and Non-Hispanics.
        J Am Soc Nephrol. Nov. 2016; 27: 3488-3497https://doi.org/10.1681/ASN.2015050570
        • Chesnaye N.C.
        • Meuleman Y.
        • de Rooij E.N.M.
        • et al.
        Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease.
        Clinical Journal of the American Society of Nephrology. 2022; 17: 205https://doi.org/10.2215/CJN.08730621
        • Fryback D.G.
        • Dunham N.C.
        • Palta M.
        • et al.
        US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.
        Med Care. Dec 2007; 45: 1162-1170https://doi.org/10.1097/MLR.0b013e31814848f1
        • Burström K.
        • Johannesson M.
        • Diderichsen F.
        Swedish population health-related quality of life results using the EQ-5D.
        Quality of life research. 2001; 10: 621-635
        • Vigneshwaran E.
        • Padmanabhareddy Y.
        • Devanna N.
        • Alvarez-Uria G.
        Gender Differences in Health Related Quality of Life of People Living with HIV/AIDS in the Era of Highly Active Antiretroviral Therapy.
        N Am J Med Sci. Feb. 2013; 5: 102-107https://doi.org/10.4103/1947-2714.107526
        • Mujais S.K.
        • Story K.
        • Brouillette J.
        • et al.
        Health-related quality of life in CKD Patients: correlates and evolution over time.
        Clin J Am Soc Nephrol. Aug. 2009; 4: 1293-1301https://doi.org/10.2215/CJN.05541008
        • Kelley K.
        • Aricak O.T.
        • Light R.P.
        • Agarwal R.
        Proteinuria is a determinant of quality of life in diabetic nephropathy: modeling lagged effects with path analysis.
        American Journal of Nephrology. 2007; 27: 488-494
        • Flint K.M.
        • Schmiege S.J.
        • Allen L.A.
        • Fendler T.J.
        • Rumsfeld J.
        • Bekelman D.
        Health status trajectories among outpatients with heart failure.
        Journal of pain and symptom management. 2017; 53: 224-231
        • Nassif M.E.
        • Windsor S.L.
        • Borlaug B.A.
        • et al.
        The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
        Nature medicine. 2021; 27: 1954-1960
        • Butler J.
        • Anker S.D.
        • Filippatos G.
        • et al.
        Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
        Eur Heart J. Mar 31. 2021; 42: 1203-1212https://doi.org/10.1093/eurheartj/ehaa1007
        • Heerspink H.J.L.
        • Stefansson B.V.
        • Chertow G.M.
        • et al.
        Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial.
        Nephrol Dial Transplant. Feb 1. 2020; 35: 274-282https://doi.org/10.1093/ndt/gfz290
      3. Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models. Journal of Statistical Software. 12/06 2017;82(13):1 - 26. doi:10.18637/jss.v082.i13